EUVIMEDEUVIMED entdecken
Crossref

Intranasal Absorption Enhancement of Antidiabetic Therapeuticals by the Functional Peptide Segment of Latroeggtoxin-VI

Minglu Sun, Panfeng Yin, Si Chen, Xianchun Wang iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Minglu Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Protein Chemistry Laboratory, College of Life Sciences, Hunan Normal University, Changsha 410081, Hunan, China. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Spider Venoms, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Latroeggtoxin-VI (LETX-VI) is an active peptide found from the eggs of the spider Latrodectus tredecimguttatus. Previous studies demonstrated that LETX-VI can penetrate the plasma membrane of secretory PC12 cells and its 17-residue C-terminal sequence is the functional peptide segment (FPS), suggesting that the FPS may act as a vector for drug transmembrane delivery. In the present proof-of-concept study, the ability and efficiency of FPS to transmembrane delivery of antidiabetic therapeuticals were preliminarily evaluated. The FPS was covalently fused with a glucagon-like peptide-1 analogue (FPS-GLP) or insulin (FPS-Ins) using solid phase chemical synthesis or heterologous expression, respectively. Western blot analysis indicated that, compared with GLP-1 analogue that itself could hardly enter the cultured A549 cells, FPS-GLP efficiently entered the cells in a concentration-dependent manner, confirming the vector role of FPS in transmembrane delivery of drugs. When intranasally administrated to mice, FPS-GLP showed the hypoglycemic effect significantly superior to that of GLP-1 analogue, and the hypoglycemic effect of intranasally administrated FPS-Ins was approximately comparable to that of the intramuscularly injected FPS-Ins. These observations demonstrated that FPS can act as a vector to efficiently enhance the intranasal absorption of proteinaceous drugs, showing application prospect in combating diabetes mellitus and related CNS disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsSpider VenomsPeptidesAnimalsMiceAdministration, IntranasalHumansInsulinDiabetes Mellitus, ExperimentalMaleRatsGlucagon-Like Peptide 1A549 CellsDrug Delivery SystemsPC12 Cells

Stichwörter der Autor:innen

blood glucose levelcell-penetrating peptidefunctional peptide segmentintranasal administrationlatroeggtoxin-VI

Substanzen

Hypoglycemic AgentsInsulinSpider VenomsGlucagon-Like Peptide 1Peptides

Autor:innen und Institutionen

  • Protein Chemistry Laboratory, College of Life Sciences, Hunan Normal University, Changsha 410081, Hunan, China.

ORCID-Profile: Xianchun Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, M., Yin, P., Chen, S., & Wang, X. (2025). Intranasal Absorption Enhancement of Antidiabetic Therapeuticals by the Functional Peptide Segment of Latroeggtoxin-VI. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00293

Vancouver

Sun M, Yin P, Chen S, Wang X. Intranasal Absorption Enhancement of Antidiabetic Therapeuticals by the Functional Peptide Segment of Latroeggtoxin-VI. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00293

BibTeX
@article{Sun2025,
  author = {Sun, Minglu and Yin, Panfeng and Chen, Si and Wang, Xianchun},
  title = {Intranasal Absorption Enhancement of Antidiabetic Therapeuticals by the Functional Peptide Segment of Latroeggtoxin-VI},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00293}
}
Kostenlos starten →